FDA Watch: Lab Industry Objects to Agency's New LDT Proposal

 Email not displaying correctly? View it in your browser.
  Lab and Pathology Insider Logo  
September 11, 2018  
placeholder NEW PRODUCTS
FDA Watch: Lab Industry Objects to Agency's New LDT Proposal
From - Laboratory Industry Report
On Aug. 3, the Food and Drug Administration heated the long simmering controversy over FDA regulation of laboratory developed tests (LDTs) to full boil by submitting…
Read More
     
placeholder COMPLIANCE PLANS
OIG Monthly Work Plan Review: August 2018
From - G2 Compliance Advisor
Of the 12 new Work Plan items, four have direct implications for labs and billing of lab tests…
Read More
     
placeholder TESTING STRATEGY
Hidden Blood in Stool May Indicate Higher All-Cause Death Risk
From - Diagnostic Testing & Emerging Technologies
"Invisible" blood in stool may predict death from a wide range of causes, not just colorectal cancer, according to a study published July 16 in…
Read More
     
placeholder LAB SAFETY
The Safety Interpretation
From - National Intelligence Report
When hospitals were placed on OSHA's list of "high-risk" workplaces, no one had to ask why. OSHA adjusts that list based on the number of injuries that occur on the job…
Read More

 

For questions concerning delivery of this email, please contact customer service at:
(888) 729-2315 | customerservice@plainlanguagemedia.com

Copyright © 2018, All rights reserved.
Plain Language Media LLLP
PO Box 509, New London, CT 06320